News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Álvaro Pinto: Presenting our ongoing research in proteomic profiles in MIBC at EAU25
Álvaro Pinto/LinkedIn
Mar 19, 2025, 07:29

Álvaro Pinto: Presenting our ongoing research in proteomic profiles in MIBC at EAU25

Álvaro Pinto, Medical Oncologist at University Hospital La Paz, Madrid, shared a post on LinkedIn:

“This Friday, March 21st, I will be at EAU25 presenting more data about our ongoing research in proteomic profiles and response to neoadjuvant chemotherapy in MIBC. Hope you can join!”

Álvaro Pinto

Alvaro Pinto cancer Cancer research EAU25 OncoDaily Oncology
Special Coverage
Blog
Mar 19, 2025, 07:29
Álvaro Pinto: Presenting our ongoing research in proteomic profiles in MIBC at EAU25
Blog
Mar 19, 2025, 07:26
Salvatore Provenzano: The Network of Expertise on AYAs with cancer
Blog
Mar 19, 2025, 07:19
Breelyn Wilky Discusses Promising Phase 1 Results of BOT/BAL in Advanced Sarcomas - Agenus
Blog
Mar 19, 2025, 07:15
Remziye Semerci: Enhancing digital skills for better patient care with The TRANSITION project
Blog
Mar 19, 2025, 07:14
Sheraz Azhar: Beyond Medicine - Innovating Cancer Care with Compassion
Blog
Mar 19, 2025, 07:11
The 1st ESO College Convention in Budapest
Blog
Mar 19, 2025, 07:09
Jemma Arakelyan: I will be attending the Lindau Meeting
Blog
Mar 19, 2025, 06:47
Zainab Shinkafi-Bagudu: Honored to be a panelist at the Federal Ministry of Women Affairs' Nigerian Women’s Day commemoration
Blog
Mar 19, 2025, 06:37
Polona Safaric Tepes: The Forgotten Aspect or Missed Opportunity - Women's Health
Blog
Mar 19, 2025, 06:30
Selcuk Erdem: Is it prime time for SBRT on primary RCC treatment?
Science
Mar 19, 2025, 06:22
New findings from the MINDACT phase III trial - EORTC
Societies
Mar 19, 2025, 06:03
Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer